|
Molten Ventures PLC on Thursday announced a £7 million investment, together with Greek seed-stage fund Marathon Venture Capital, in PolyModels Hub Ltd. The London-based, tech-focused venture capital firm said the investment is in the biotechnology software company’s Series A funding round. Molten Ventures said the funds will enable PolyModels, also headquartered in London, to expand its engineering and product teams, enhance its core platform, and reach more pharmaceutical companies globally. PolyModels’ flagship product is the ModelFlow platform, which ‘brings together process knowledge, models, and collaboration tools in a unified digital environment’. ‘Scientists and engineers can use the hub to design, test and improve drug processes faster and more efficiently, ultimately saving time, reducing cost, and delivering better medicines,’ Molten Ventures said. PolyModels’ team ‘will focus on building scalable solutions for process and regulatory workflows, making it even easier for customers to adopt and benefit from their technology,’ it said. ‘PolyModels Hub is solving a real pain point for pharma teams, bringing together deep domain expertise and cutting-edge technology in a way that’s genuinely transformative,’ commented Molten Ventures Chief Executive Officer Ben Wilkinson. ‘We’re proud to support [CEO Antonio Benedetti, Chief Technology Officer Antonio Yankey, Chief Scientific Officer Harry Christodoulou] and the team as they scale their impact across the industry. ‘What impressed us most is the PolyModels Hub team’s blend of technical know-how and deep understanding of its customers’ real-world challenges. They’ve built a solution that delivers value in weeks, not years, and its rapid adoption by major pharma companies speaks volumes.’ Molten Ventures shares were 1.9% higher at 415.85 pence each in London on Thursday. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
